Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Sample Protocol for Plasma-based Colorectal Cancer Screening Research & Development

NCT04027790 is registered in ClinicalTrials.gov with Epigenomics, Inc as lead sponsor.

NCT NCT04027790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04027790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Sample Protocol for Plasma-based Colorectal Cancer Screening Research & Development
Lead sponsor
Epigenomics, Inc
Phase
Observational
Overall status
Completed
Start date
May 3, 2019
Completion date
March 31, 2020
Enrollment
354 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

colo-rectal cancer